Aimia Inc. (FRA:GA7)

Germany flag Germany · Delayed Price · Currency is EUR
1.670
+0.050 (3.09%)
At close: Mar 27, 2026
Market Cap154.14M +5.9%
Revenue (ttm)317.79M +5.0%
Net Income21.62M
EPS0.23
Shares Outn/a
PE Ratio7.13
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume13
Open1.680
Previous Close1.620
Day's Range1.670 - 1.680
52-Week Range1.420 - 1.980
Betan/a
RSI40.47
Earnings DateMar 24, 2026

About Aimia

Aimia Inc. invests in public and private companies. It operates in three segments: Bozzetto, Cortland International, and Holdings. The company, through its long-term investments, provides specialty chemicals, textiles, and water and dispersion chemical solutions in various applications, including textile, home and personal care, plasterboard, and agrochemical markets; manufactures synthetic fiber ropes, as well as offers netting solutions for maritime and other industrial customers; and manufactures and supplies ropes, slings, and tethers for a... [Read more]

Industry Chemicals and Allied Products
Founded 2005
Employees 18
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol GA7

Financial Performance

Financial numbers in CAD Financial Statements

News

Aimia Inc (AIMFF) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on ...

Aimia Inc (AIMFF) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on Opportunities

4 days ago - GuruFocus

Q4 2025 Aimia Inc Earnings Call Transcript

Q4 2025 Aimia Inc Earnings Call Transcript

4 days ago - GuruFocus

Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript

Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript

5 days ago - Seeking Alpha

AIMIA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

TORONTO , March 24, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) ("Aimia" or the "Company"), today reported its financial results for the three-month period and full year ended December 31, 2025. Al...

5 days ago - Benzinga

AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress

OCALA, Fla. — Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy trading volume exceeding 183 million share...

10 days ago - International Business Times (Australia)

Why Is AIM ImmunoTech Stock Gaining Today?

AIM ImmunoTech Inc. (AMEX: AIM) shares moved higher on Wednesday after the company secured full approval for a key cancer-related patent in Japan. • AIM ImmunoTech stock is showing exceptional streng...

10 days ago - Benzinga

AIM ImmunoTech Gains Japanese Patent Approval for Cancer Treatment

AIM ImmunoTech Gains Japanese Patent Approval for Cancer Treatment

11 days ago - GuruFocus

AIMIA DECLARES PREFERRED SHARE DIVIDENDS

TORONTO , March 16, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) today announced that its Board of Directors has declared quarterly dividends on each series of its preferred shares: A quarterly divi...

13 days ago - Benzinga

Verdict parent company GlobalData moves to Main Market of LSE

The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy. The post Verdict parent company GlobalData moves to Main Market of LSE ...

24 days ago - Verdict

AIM Collaborates with Thermo Fisher for Phase 3 Trial of Ampligen in Pancreatic Cancer

AIM Collaborates with Thermo Fisher for Phase 3 Trial of Ampligen in Pancreatic Cancer

27 days ago - GuruFocus

AIMIA PROVIDES UPDATE ON ITS SHARE BUYBACKS

TORONTO , March 2, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) announced that it repurchased and settled for cancellation a total of 107,800 of its common shares in the month of February 2026 under...

27 days ago - Benzinga

AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer

OCALA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced milestones in the expected timeline for the ongoing Phase 2 clinical study eval...

4 weeks ago - Benzinga

AIMIA ANNOUNCES DUAL LISTING ON JOHANNESBURG STOCK EXCHANGE

TORONTO , Feb. 17, 2026 /CNW/ - Aimia Inc. (TSX: AIM) ("the Company") announced today the dual listing of its common shares on the Main Board of the Johannesburg Stock Exchange (" JSE ") effective Fe...

5 weeks ago - Benzinga

IHG revenues up, ITM Power upgrades outlook and Debenhams funding round

Plus we have updates from AIM listed Helium One and Cambridge Cognition - and we turn our attention to German stocks for our Plus+ members

5 weeks ago - The Armchair Trader

Aimia Inc. (AIM:CA) M&A Call Transcript

Aimia Inc. (AIM:CA) M&A Call Transcript

6 weeks ago - Seeking Alpha

Aimia Inc. (AIM:CA) Q3 2025 Earnings Call Transcript

Aimia Inc. ( AIM:CA) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Joseph Racanelli - Vice President of Investor Relations & Communications Rhys Summerton - Executive Chair...

4 months ago - Seeking Alpha

Aimia Inc. (AIMFF) Q2 2025 Earnings Call Transcript

Aimia Inc. (AIMFF) Q2 2025 Earnings Call Transcript

8 months ago - Seeking Alpha

Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript

Aimia Inc. (OTCPK:AIMFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Rhys Summerton - Executive Chairman Steven L...

11 months ago - Seeking Alpha

Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript

Aimia Inc. (OTCPK:AIMFF) Q4 2024 Results Conference Call March 28, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Tom Finke - Executive Chairman Rhys Summert...

1 year ago - Seeking Alpha

Aimia Inc. (AIMFF) Q3 2024 Earnings Call Transcript

Aimia Inc. (OTCPK:AIMFF) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Tom Finke - Executive Chairman Steve Leo...

1 year ago - Seeking Alpha

Aimia Inc. (AIMFF) Q2 2024 Earnings Call Transcript

Aimia Inc. (OTCPK:AIMFF) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Joe Racanelli - Investor Relations Tom Finke - Executive Chairman Steve Leonard - President & ...

1 year ago - Seeking Alpha

Aimia Inc. (AIMFF) Q1 2024 Earnings Call Transcript

Aimia Inc. (OTCPK:AIMFF) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Joe Racanelli - VP, IR and Communications Tom Finke - Executive Chairman Steve Leonard - Chief Fin...

2 years ago - Seeking Alpha

Aimia Inc. (AIMFF) Q4 2023 Earnings Call Transcript

Aimia Inc. (AIMFF) Q4 2023 Earnings Call Transcript

2 years ago - Seeking Alpha

Aimia, Inc. (AIMFF) Q3 2023 Earnings Call Transcript

Aimia, Inc. (OTCPK:AIMFF) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Albert Matousek - IR Phil Mittleman - CEO Michael Lehmann - President Steve Leonard - CFO C...

2 years ago - Seeking Alpha

Aimia Inc. (AIMFF) Q2 2023 Earnings Call Transcript

Aimia Inc. (OTCPK:AIMFF) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ET Company Participants Albert Matousek - Head of Investor Relations and Communications Phil Mittleman - Chief Executi...

2 years ago - Seeking Alpha